Skip to content

Amikacin

by Ab Biodisk Sweden(FDA 510(k) applicant) 510(k)

510(k) K970210 Product code JWY

Overview

Amikacin is a Manual Antimicrobial Susceptibility Test System used to determine the in vitro susceptibility of bacterial isolates to amikacin. This device aids microbiologists in identifying whether bacterial pathogens are resistant or susceptible to the antibiotic, facilitating targeted antimicrobial therapy decisions. It falls under the classification of microbiology test systems, adhering to standardized susceptibility testing protocols.

The system is supplied as a manual test kit for laboratory use, requiring preparation and interpretation by trained personnel. It is intended for single-use per test and is not sterile, as it is designed for use in controlled microbiology environments. The device is regulated under FDA 510(k) clearance (K970210) with product code JWY, classified as a Class II medical device. Storage and handling follow standard microbiological laboratory practices.

Summary written by AI from registry data, 1 Oct 2026.Not verified

About this summary

This description and any FAQs on this page were generated automatically and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Regulatory status

as of 26 Oct 2026

Recall ongoing. 1 ongoing FDA recall. See recalls

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK970210 Date1 May 1997ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

1 recall · 1 ongoing · FDA

    • Ongoing Z-0817-2023 FDA Class II initiated 9 Nov 2022

    As the temperature and time out of range was exceeded, product performances cannot be guaranteed

Specification

510(k) · synced 5 Oct 2026

510(k) Number
FDA Product Code
JWY
Device Class
Class II
Regulation
21 CFR Part 866.1640
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Other devices from Ab Biodisk

See all devices from Ab Biodisk →

Questions

  • What is the Amikacin Manual Antimicrobial Susceptibility Test System used for?

    This test system is designed to evaluate the in vitro susceptibility of bacterial isolates to amikacin, helping microbiologists determine whether pathogens are resistant or susceptible to the antibiotic. By providing clear results, it supports informed decisions for targeted antimicrobial therapy, ensuring appropriate treatment selection in clinical settings.

  • How is the Amikacin test kit supplied and intended for use?

    The kit is supplied as a manual test kit for laboratory use only. It requires preparation and interpretation by trained personnel following standardized microbiology protocols. Each test is intended for single-use, and the kit is not sterile, as it is engineered for controlled laboratory environments where sterility is not a primary concern.

  • Is the Amikacin test kit sterile, and what are its storage requirements?

    The kit is not sterile, as it is designed for use in microbiology laboratories where standard aseptic techniques are already in place. Storage and handling should follow general microbiological laboratory practices to maintain test integrity and prevent contamination. Always refer to the manufacturer’s instructions for specific storage conditions.

  • What regulatory clearance does the Amikacin test kit hold, and what class is it?

    The Amikacin Manual Antimicrobial Susceptibility Test System holds FDA 510(k) clearance under the reference number K970210. It is classified as a Class II medical device, indicating it poses minimal potential risk and is subject to special controls to ensure safety and effectiveness.

  • Can this test kit be reused, and what are its key specifications?

    The kit is explicitly designed for single-use per test, meaning each test requires a new kit. Key specifications include its classification as a manual antimicrobial susceptibility test system, adherence to standardized testing protocols, and its regulatory filing under product code JWY. The system is intended for in vitro use only and does not require sterility due to its controlled laboratory environment.

Properties & raw data

Show properties, registry sources and raw records

Sources (1)

  • FDA 510(k) K970210 24 fields · synced 5 Oct 2026